Psoriasis Treatments Show No Impact on Blood Glucose Levels: Study
A new study published in Dermatology just put to rest the idea that biologics or methotrexate might double as anti-diabetes medications for people with psoriasis. Researchers tracked HbA1c levels in 386 psoriasis patients over the course of a year—those treated with TNF-α inhibitors (like adalimumab and infliximab), IL-17 inhibitors (brodalumab, ixekizumab, secukinumab), IL-12/23 inhibitor (ustekinumab), […]